Physician profile
Robert C Dawson
NPI 1972561397
$4,893.36
in general payments reported to CMS, 2019-2025
21 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,661 · 2020: $372 · 2021: $646 · 2022: $1,124 · 2023: $530 · 2024: $421 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,012.34 | 2019-2024 | Axs Vecta 71, Actishield Cf, Target |
| Imperative Care, INC | $1,009.98 | 2020-2025 | Zoom Reperfusion Catheter, Zoom 88-T Large Distal Platform, Tracstar Large Distal Platform |
| Penumbra, INC. | $971.15 | 2019-2023 | Penumbra System |
| Microvention, INC. | $296.01 | 2019-2022 | |
| Irras USA, INC. | $277.95 | 2019 | |
| Depuy Synthes Sales INC. | $277.12 | 2020-2022 | |
| Globus Medical, INC. | $245.32 | 2019-2022 | |
| Medical Device Business Services, INC. | $140.71 | 2023 | |
| Medtronic USA, INC. | $135.86 | 2019 | |
| W. L. Gore & Associates, INC. | $123.45 | 2019 | |
| Cerapedics INC. | $120.78 | 2022 | |
| Corelink, LLC | $63.70 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.45 | 2023-2024 | Ninlaro |
| Coherus Oncology, INC. | $32.11 | 2020 | |
| Silk Road Medical, INC. | $29.80 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Balt USA, LLC | $28.61 | 2021 | |
| Abbvie INC. | $21.53 | 2024 | |
| Clovis Oncology, INC. | $20.21 | 2020 | |
| Merz Pharmaceuticals, LLC | $18.00 | 2023 | Xeomin |
| Astrazeneca Pharmaceuticals LP | $14.01 | 2022 | |
| Strongbridge US INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.